UK markets open in 1 hour 18 minutes
NIKKEI 225
39,074.97 +457.87 (+1.19%) HANG SENG
18,853.15 -342.45 (-1.78%) CRUDE OIL
77.01 -0.56 (-0.72%) GOLD FUTURES
2,371.90 -21.00 (-0.88%) DOW
39,671.04 -201.95 (-0.51%) Bitcoin GBP
54,483.01 -362.30 (-0.66%)
Morinaga Milk Industry Co., Ltd. (MO8.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
At close: 08:06AM CEST
| Previous close | 18.70 |
| Open | 18.60 |
| Bid | 18.70 x 400000 |
| Ask | 19.80 x 400000 |
| Day's range | 18.60 - 18.60 |
| 52-week range | 14.50 - 19.90 |
| Volume | |
| Avg. volume | 0 |
| Market cap | 1.657B |
| Beta (5Y monthly) | 0.03 |
| PE ratio (TTM) | 4.54 |
| EPS (TTM) | 4.10 |
| Earnings date | 07 Aug 2024 - 12 Aug 2024 |
| Forward dividend & yield | 0.54 (2.86%) |
| Ex-dividend date | 27 Sept 2024 |
| 1y target est | N/A |
Business WireMorinaga Milk’s Probiotic Bifidobacterium breve B-3 Receives Approval of Individual Recognized Registration in South Korea
TOKYO, November 17, 2023--Morinaga Milk's Bifidobacterium breve B-3 received Individually Recognized approval in South Korea for its clinical efficacy on body fat reduction.
Business WireMorinaga Milk's Probiotic Bifidobacterium longum subsp. longum BB536 Receives ANVISA Approval with Gut Health Functional Claim in Brazil
TOKYO, September 07, 2023--Morinaga Milk Industry Co., Ltd. (TOKYO:2264), a leading Japanese dairy product company, is pleased to announce that its proprietary probiotic strain Bifidobacterium longum subsp. longum BB536 (hereafter referred to as Bifidobacterium longum BB536) has obtained approval from the Brazilian Health Regulatory Agency (Agência Nacional de Vigilância Sanitária, ANVISA). This approval, granted on July 27, 2023, allows for the utilization of Bifidobacterium longum BB536 in die
© 2024 Yahoo. All rights reserved.